Skip to content
20-F

Annual Report (Foreign)

Correvio Pharma Corp.

0001193125-20-127179

← back to feed
Filed
Apr 30, 2020 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted FY 2019 · Dec 31, 2019 44.28M sh
Shares Diluted FY 2019 · Dec 31, 2018 35.15M sh
Shares Diluted FY 2019 · Dec 31, 2017 33.23M sh
Shares Outstanding FY 2019 · Dec 31, 2019 55.38M sh
Capex FY 2019 · Dec 31, 2019 $129K
Capex FY 2019 · Dec 31, 2018 $284K
Capex FY 2019 · Dec 31, 2017 $5K
Operating Cash Flow FY 2019 · Dec 31, 2019 −$27.08M
Operating Cash Flow FY 2019 · Dec 31, 2018 −$25.78M
Operating Cash Flow restated FY 2019 · Dec 31, 2017 −$24.82M
Long Term Debt FY 2019 · Dec 31, 2019 $27.24M
Long Term Debt FY 2019 · Dec 31, 2018 $41.52M
Short Term Debt FY 2019 · Dec 31, 2019 $17.69M
Cash And Equivalents FY 2019 · Dec 31, 2019 $13.3M
Cash And Equivalents FY 2019 · Dec 31, 2018 $15.6M
Stockholders Equity FY 2019 · Dec 31, 2019 −$834K
Stockholders Equity FY 2019 · Dec 31, 2018 $6.91M
Stockholders Equity FY 2019 · Dec 31, 2017 $16.19M
Stockholders Equity FY 2019 · Dec 31, 2016 $34.02M
Current Liabilities FY 2019 · Dec 31, 2019 $29.8M
Current Liabilities FY 2019 · Dec 31, 2018 $9.4M
Total Liabilities FY 2019 · Dec 31, 2019 $59.73M
Total Liabilities FY 2019 · Dec 31, 2018 $52.73M
Current Assets FY 2019 · Dec 31, 2019 $31.77M
Current Assets FY 2019 · Dec 31, 2018 $30.29M
Total Assets FY 2019 · Dec 31, 2019 $58.89M
Total Assets FY 2019 · Dec 31, 2018 $59.64M
Sga Expense FY 2019 · Dec 31, 2019 $46.32M
Sga Expense FY 2019 · Dec 31, 2018 $42.58M
Sga Expense FY 2019 · Dec 31, 2017 $36.69M
Net Income FY 2019 · Dec 31, 2019 −$35.18M
Net Income FY 2019 · Dec 31, 2018 −$16.58M
Net Income FY 2019 · Dec 31, 2017 −$29.81M
Operating Income FY 2019 · Dec 31, 2019 −$27.45M
Operating Income FY 2019 · Dec 31, 2018 −$26.34M
Operating Income FY 2019 · Dec 31, 2017 −$22.98M
Gross Profit FY 2019 · Dec 31, 2019 $22.81M
Gross Profit FY 2019 · Dec 31, 2018 $20.38M
Gross Profit FY 2019 · Dec 31, 2017 $17.23M
Cost Of Revenue FY 2019 · Dec 31, 2019 $9.83M
Cost Of Revenue FY 2019 · Dec 31, 2018 $8.29M
Cost Of Revenue FY 2019 · Dec 31, 2017 $6.78M
Revenue FY 2019 · Dec 31, 2019 $32.63M
Revenue FY 2019 · Dec 31, 2018 $28.67M
Revenue FY 2019 · Dec 31, 2017 $24.01M